{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:15:17Z","timestamp":1782310517543,"version":"3.54.5"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18TPA34170206"],"award-info":[{"award-number":["18TPA34170206"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nebraska Research Initiative Grant"},{"name":"Biomedical Research Grant, University of Nebraska-Lincoln"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Coxsackievirus B3 (CVB3), is commonly implicated in myocarditis, which can lead to dilated cardiomyopathy, in addition to causing acute pancreatitis and meningitis. Yet, no vaccines are currently available to prevent this infection. Here, we describe the derivation of a live attenuated vaccine virus, termed mutant (Mt) 10, encoding a single amino acid substitution H790A within the viral protein 1, that prevents CVB3 infection in mice and protects from both myocarditis and pancreatitis in challenge studies. We noted that animals vaccinated with Mt 10 developed virus-neutralizing antibodies, predominantly containing IgG2a and IgG2b, and to a lesser extent IgG3 and IgG1. Furthermore, by using major histocompatibility complex class II dextramers and tetramers, we demonstrated that Mt 10 induces antigen-specific T cell responses that preferentially produce interferon-\u03b3. Finally, neither vaccine recipients nor those challenged with the wild-type virus revealed evidence of autoimmunity or cardiac injury as determined by T cell response to cardiac myosin and measurement of circulating cardiac troponin I levels, respectively. Together, our data suggest that Mt 10 is a vaccine candidate that prevents CVB3 infection through the induction of neutralizing antibodies and antigen-specific T cell responses, the two critical components needed for complete protection against virus infections in vaccine studies.<\/jats:p>","DOI":"10.1038\/s41598-021-90434-w","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T10:03:10Z","timestamp":1623664990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis"],"prefix":"10.1038","volume":"11","author":[{"given":"Ninaad","family":"Lasrado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunakumar","family":"Gangaplara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandirasegaran","family":"Massilamany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajkumar","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Shelbourn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima T.","family":"Rasquinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh H.","family":"Basavalingappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Delhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hua","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asit K.","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"90434_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1542\/pir.19-6-183","volume":"19","author":"T Zaoutis","year":"1998","unstructured":"Zaoutis, T. & Klein, J. D. Enterovirus infections. Pediatr. Rev. Am. Acad. Pediatr. 19, 183\u2013191 (1998).","journal-title":"Pediatr. Rev. Am. Acad. Pediatr."},{"key":"90434_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.virol.2010.12.014","volume":"411","author":"RE Rhoades","year":"2011","unstructured":"Rhoades, R. E., Tabor-Godwin, J. M., Tsueng, G. & Feuer, R. Enterovirus infections of the central nervous system. Virology 411, 288\u2013305. https:\/\/doi.org\/10.1016\/j.virol.2010.12.014 (2011).","journal-title":"Virology"},{"key":"90434_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0065-2776(08)00604-4","volume":"99","author":"D Cihakova","year":"2008","unstructured":"Cihakova, D. & Rose, N. R. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 99, 95\u2013114. https:\/\/doi.org\/10.1016\/S0065-2776(08)00604-4 (2008).","journal-title":"Adv. Immunol."},{"key":"90434_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1089\/vim.2004.17.358","volume":"17","author":"S Huber","year":"2004","unstructured":"Huber, S. & Ramsingh, A. I. Coxsackievirus-induced pancreatitis. Viral Immunol. 17, 358\u2013369. https:\/\/doi.org\/10.1089\/vim.2004.17.358 (2004).","journal-title":"Viral Immunol."},{"key":"90434_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/jmv.21998","volume":"83","author":"AH Wong","year":"2011","unstructured":"Wong, A. H., Lau, C. S., Cheng, P. K., Ng, A. Y. & Lim, W. W. Coxsackievirus B3-associated aseptic meningitis: an emerging infection in Hong Kong. J. Med. Virol. 83, 483\u2013489. https:\/\/doi.org\/10.1002\/jmv.21998 (2011).","journal-title":"J. Med. Virol."},{"issue":"Suppl D","key":"90434_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/eurheartj\/12.suppl_D.56","volume":"12","author":"LC Archard","year":"1991","unstructured":"Archard, L. C. et al. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur. Heart J. 12(Suppl D), 56\u201359 (1991).","journal-title":"Eur. Heart J."},{"key":"90434_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","volume":"111","author":"U Kuhl","year":"2005","unstructured":"Kuhl, U. et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction. Circulation 111, 887\u2013893. https:\/\/doi.org\/10.1161\/01.CIR.0000155616.07901.35 (2005).","journal-title":"Circulation"},{"key":"90434_CR8","doi-asserted-by":"crossref","unstructured":"Martino, T., Liu, P. & Sole, M. J. Enteroviral myocarditis and dialted cardiomyopathy: a review of clinical and experimental studies. In Human Enterovirus infections., 291\u2013351 (ASM, 1995).","DOI":"10.1128\/9781555818326.ch14"},{"key":"90434_CR9","first-page":"275","volume":"323","author":"NM Chapman","year":"2008","unstructured":"Chapman, N. M. & Kim, K. S. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy. Curr. Top Microbiol. Immunol. 323, 275\u2013292 (2008).","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"90434_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.clim.2012.07.003","volume":"144","author":"A Gangaplara","year":"2012","unstructured":"Gangaplara, A. et al. Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-alpha-reactive CD4 T cells in A\/J mice. Clin. Immunol. 144, 237\u2013249. https:\/\/doi.org\/10.1016\/j.clim.2012.07.003 (2012).","journal-title":"Clin. Immunol."},{"key":"90434_CR11","doi-asserted-by":"publisher","first-page":"e0131052","DOI":"10.1371\/journal.pone.0131052","volume":"10","author":"C Massilamany","year":"2015","unstructured":"Massilamany, C. et al. Mutations in the 5\u2019 NTR and the non-structural protein 3A of the coxsackievirus B3 selectively attenuate myocarditogenicity. PLoS ONE 10, e0131052. https:\/\/doi.org\/10.1371\/journal.pone.0131052 (2015) (PMCID: PMC4476614).","journal-title":"PLoS ONE"},{"key":"90434_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/v12030347","author":"N Lasrado","year":"2020","unstructured":"Lasrado, N. et al. Identification of immunogenic epitopes that permit the detection of antigen-specific T cell responses in multiple serotypes of group B coxsackievirus infections. Viruses https:\/\/doi.org\/10.3390\/v12030347 (2020) (PMCID: PMC7150766).","journal-title":"Viruses"},{"key":"90434_CR13","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/0161-5890(92)90221-I","volume":"29","author":"GK Lewis","year":"1992","unstructured":"Lewis, G. K. & Feng, C. P. Intrinsic immunogenicity of an internal VP1 T-B epitope pair of type 1 poliovirus. Mol. Immunol. 29, 1477\u20131485 (1992).","journal-title":"Mol. Immunol."},{"key":"90434_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/13550289509111014","volume":"1","author":"A Senkowski","year":"1995","unstructured":"Senkowski, A., Shim, B. & Roos, R. P. The effect of Theiler\u2019s murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virus-induced central nervous system disease. J. Neurovirol. 1, 101\u2013110 (1995).","journal-title":"J. Neurovirol."},{"key":"90434_CR15","doi-asserted-by":"publisher","first-page":"e15300","DOI":"10.1371\/journal.pone.0015300","volume":"5","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. Natural type 3\/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region. PLoS ONE 5, e15300. https:\/\/doi.org\/10.1371\/journal.pone.0015300 (2011).","journal-title":"PLoS ONE"},{"key":"90434_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1107\/S0907444995002253","volume":"51","author":"JK Muckelbauer","year":"1995","unstructured":"Muckelbauer, J. K. et al. Structure determination of coxsackievirus B3 to 3.5 A resolution. Acta Crystallogr. D Biol. Crystallogr. 51, 871\u2013887. https:\/\/doi.org\/10.1107\/S0907444995002253 (1995).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"90434_CR17","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/nsb1001-874nsb1001-874[pii]","volume":"8","author":"Y He","year":"2001","unstructured":"He, Y. et al. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat. Struct. Biol. 8, 874\u2013878. https:\/\/doi.org\/10.1038\/nsb1001-874nsb1001-874[pii] (2001).","journal-title":"Nat. Struct. Biol."},{"key":"90434_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/0952-7915(91)90037-2","volume":"3","author":"CL Schultz","year":"1991","unstructured":"Schultz, C. L. & Coffman, R. L. Control of isotype switching by T cells and cytokines. Curr. Opin. Immunol. 3, 350\u2013354. https:\/\/doi.org\/10.1016\/0952-7915(91)90037-2 (1991).","journal-title":"Curr. Opin. Immunol."},{"key":"90434_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.molimm.2020.06.017","volume":"124","author":"RH Basavalingappa","year":"2020","unstructured":"Basavalingappa, R. H. et al. Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of CVB3 infection. Mol. Immunol. 124, 218\u2013228. https:\/\/doi.org\/10.1016\/j.molimm.2020.06.017 (2020) (PMCID: PMC7363587).","journal-title":"Mol. Immunol."},{"key":"90434_CR20","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1084\/jem.182.5.1291","volume":"182","author":"DL Donermeyer","year":"1995","unstructured":"Donermeyer, D. L., Beisel, K. W., Allen, P. M. & Smith, S. C. Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J. Exp. Med. 182, 1291\u20131300 (1995).","journal-title":"J. Exp. Med."},{"key":"90434_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/01.cir.88.1.101","volume":"88","author":"JE Adams 3rd","year":"1993","unstructured":"Adams, J. E. 3rd. et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 88, 101\u2013106. https:\/\/doi.org\/10.1161\/01.cir.88.1.101 (1993).","journal-title":"Circulation"},{"key":"90434_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-00435-x","author":"C Tschope","year":"2020","unstructured":"Tschope, C. et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat. Rev. Cardiol. https:\/\/doi.org\/10.1038\/s41569-020-00435-x (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"90434_CR23","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/rmv.2131","volume":"30","author":"N Lasrado","year":"2020","unstructured":"Lasrado, N. & Reddy, J. An overview of the immune mechanisms of viral myocarditis. Rev. Med. Virol. 30, 2131. https:\/\/doi.org\/10.1002\/rmv.2131 (2020).","journal-title":"Rev. Med. Virol."},{"key":"90434_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00192","author":"N Lasrado","year":"2020","unstructured":"Lasrado, N., Yalaka, B. & Reddy, J. Triggers of inflammatory heart disease. Front. Cell Dev. Biol. https:\/\/doi.org\/10.3389\/fcell.2020.00192 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"90434_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.virol.2017.09.017","volume":"512","author":"CT Flynn","year":"2017","unstructured":"Flynn, C. T., Kimura, T., Frimpong-Boateng, K., Harkins, S. & Whitton, J. L. Immunological and pathological consequences of coxsackievirus RNA persistence in the heart. Virology 512, 104\u2013112. https:\/\/doi.org\/10.1016\/j.virol.2017.09.017 (2017).","journal-title":"Virology"},{"key":"90434_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1159\/000115950","volume":"50","author":"I Seo","year":"2007","unstructured":"Seo, I. et al. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication. Intervirology 50, 447\u2013453. https:\/\/doi.org\/10.1159\/000115950 (2007).","journal-title":"Intervirology"},{"key":"90434_CR27","first-page":"2197","volume":"150","author":"H Zhang","year":"1997","unstructured":"Zhang, H. et al. Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain. Am. J. Pathol. 150, 2197\u20132207 (1997).","journal-title":"Am. J. Pathol."},{"key":"90434_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.virol.2004.09.035","volume":"330","author":"IP Hunziker","year":"2004","unstructured":"Hunziker, I. P., Harkins, S., Feuer, R., Cornell, C. T. & Whitton, J. L. Generation and analysis of an RNA vaccine that protects against coxsackievirus B3 challenge. Virology 330, 196\u2013208. https:\/\/doi.org\/10.1016\/j.virol.2004.09.035 (2004).","journal-title":"Virology"},{"key":"90434_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12033-007-0019-z","volume":"36","author":"MB M'Hadheb-Gharbi","year":"2007","unstructured":"M\u2019Hadheb-Gharbi, M. B., Paulous, S., Aouni, M., Kean, K. M. & Gharbi, J. The substitution U475 \u2013> C with Sabin3-like mutation within the IRES attenuate Coxsackievirus B3 cardiovirulence. Mol. Biotechnol. 36, 52\u201360. https:\/\/doi.org\/10.1007\/s12033-007-0019-z (2007).","journal-title":"Mol. Biotechnol."},{"key":"90434_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12934-019-1115-z","volume":"18","author":"X Qi","year":"2019","unstructured":"Qi, X., Lu, Q., Hu, J. & Xiong, S. Spontaneous C-cleavage of a truncated intein as fusion tag to produce tag-free VP1 inclusion body nanoparticle vaccine against CVB3-induced viral myocarditis by the oral route. Microb. Cell Fact. 18, 66. https:\/\/doi.org\/10.1186\/s12934-019-1115-z (2019).","journal-title":"Microb. Cell Fact."},{"key":"90434_CR31","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.vaccine.2004.10.008","volume":"23","author":"JY Kim","year":"2005","unstructured":"Kim, J. Y. et al. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge. Vaccine 23, 1672\u20131679. https:\/\/doi.org\/10.1016\/j.vaccine.2004.10.008 (2005).","journal-title":"Vaccine"},{"key":"90434_CR32","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1016\/j.vaccine.2014.05.052","volume":"32","author":"F Wu","year":"2014","unstructured":"Wu, F., Fan, X., Yue, Y., Xiong, S. & Dong, C. A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis. Vaccine 32, 3917\u20133926. https:\/\/doi.org\/10.1016\/j.vaccine.2014.05.052 (2014).","journal-title":"Vaccine"},{"key":"90434_CR33","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.vaccine.2012.01.061","volume":"30","author":"L Zhang","year":"2012","unstructured":"Zhang, L. et al. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis. Vaccine 30, 2301\u20132308. https:\/\/doi.org\/10.1016\/j.vaccine.2012.01.061 (2012).","journal-title":"Vaccine"},{"key":"90434_CR34","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.vaccine.2009.01.008","volume":"27","author":"JH Park","year":"2009","unstructured":"Park, J. H. et al. Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis. Vaccine 27, 1974\u20131983. https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.008 (2009).","journal-title":"Vaccine"},{"key":"90434_CR35","doi-asserted-by":"publisher","first-page":"eaaz2433","DOI":"10.1126\/sciadv.aaz2433","volume":"6","author":"VM Stone","year":"2020","unstructured":"Stone, V. M. et al. A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates. Sci. Adv. 6, eaaz2433. https:\/\/doi.org\/10.1126\/sciadv.aaz2433 (2020).","journal-title":"Sci. Adv."},{"key":"90434_CR36","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson, J. M. et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320\u20131323. https:\/\/doi.org\/10.1126\/science.275.5304.1320 (1997).","journal-title":"Science"},{"key":"90434_CR37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijcard.2014.09.136","volume":"177","author":"C Massilamany","year":"2014","unstructured":"Massilamany, C., Gangaplara, A. & Reddy, J. Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy. Int. J. Cardiol. 177, 330\u2013339. https:\/\/doi.org\/10.1016\/j.ijcard.2014.09.136 (2014).","journal-title":"Int. J. Cardiol."},{"key":"90434_CR38","first-page":"177","volume":"323","author":"D Marchant","year":"2008","unstructured":"Marchant, D., Si, X., Luo, H., McManus, B. & Yang, D. The impact of CVB3 infection on host cell biology. Curr. Top Microbiol. Immunol. 323, 177\u2013198 (2008).","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"90434_CR39","doi-asserted-by":"publisher","first-page":"9844","DOI":"10.1128\/JVI.71.12.9844-9848.1997","volume":"71","author":"DR Shafren","year":"1997","unstructured":"Shafren, D. R., Williams, D. T. & Barry, R. D. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J. Virol. 71, 9844\u20139848. https:\/\/doi.org\/10.1128\/JVI.71.12.9844-9848.1997 (1997).","journal-title":"J. Virol."},{"key":"90434_CR40","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1128\/JVI.01920-08","volume":"83","author":"J Steel","year":"2009","unstructured":"Steel, J. et al. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J. Virol. 83, 1742\u20131753. https:\/\/doi.org\/10.1128\/JVI.01920-08 (2009).","journal-title":"J. Virol."},{"key":"90434_CR41","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1128\/jvi.77.2.1653-1657.2003","volume":"77","author":"SS Whitehead","year":"2003","unstructured":"Whitehead, S. S. et al. A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3\u2019 untranslated region is highly attenuated and immunogenic in monkeys. J. Virol. 77, 1653\u20131657. https:\/\/doi.org\/10.1128\/jvi.77.2.1653-1657.2003 (2003).","journal-title":"J. Virol."},{"key":"90434_CR42","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1038\/s41598-019-41285-z","volume":"9","author":"PTI Yee","year":"2019","unstructured":"Yee, P. T. I. et al. Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice. Sci. Rep. 9, 4805. https:\/\/doi.org\/10.1038\/s41598-019-41285-z (2019).","journal-title":"Sci. Rep."},{"key":"90434_CR43","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/infdis\/jit207","volume":"208","author":"X Cheng","year":"2013","unstructured":"Cheng, X. et al. Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets. J. Infect. Dis. 208, 594\u2013602. https:\/\/doi.org\/10.1093\/infdis\/jit207 (2013).","journal-title":"J. Infect. Dis."},{"key":"90434_CR44","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.4049\/jimmunol.140.7.2121","volume":"140","author":"CM Snapper","year":"1988","unstructured":"Snapper, C. M., Peschel, C. & Paul, W. E. IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J. Immunol. 140, 2121\u20132127 (1988).","journal-title":"J. Immunol."},{"key":"90434_CR45","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/eji.1830200520","volume":"20","author":"E Severinson","year":"1990","unstructured":"Severinson, E., Fernandez, C. & Stavnezer, J. Induction of germ-line immunoglobulin heavy chain transcripts by mitogens and interleukins prior to switch recombination. Eur. J. Immunol. 20, 1079\u20131084. https:\/\/doi.org\/10.1002\/eji.1830200520 (1990).","journal-title":"Eur. J. Immunol."},{"key":"90434_CR46","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1002\/eji.200425719","volume":"35","author":"EK Deenick","year":"2005","unstructured":"Deenick, E. K., Hasbold, J. & Hodgkin, P. D. Decision criteria for resolving isotype switching conflicts by B cells. Eur. J. Immunol. 35, 2949\u20132955. https:\/\/doi.org\/10.1002\/eji.200425719 (2005).","journal-title":"Eur. J. Immunol."},{"key":"90434_CR47","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1084\/jem.177.4.1031","volume":"177","author":"TM McIntyre","year":"1993","unstructured":"McIntyre, T. M. et al. Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J. Exp. Med. 177, 1031\u20131037. https:\/\/doi.org\/10.1084\/jem.177.4.1031 (1993).","journal-title":"J. Exp. Med."},{"key":"90434_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1600-065x.1988.tb00741.x","volume":"102","author":"CM Snapper","year":"1988","unstructured":"Snapper, C. M., Finkelman, F. D. & Paul, W. E. Regulation of IgG1 and IgE production by interleukin 4. Immunol. Rev. 102, 51\u201375. https:\/\/doi.org\/10.1111\/j.1600-065x.1988.tb00741.x (1988).","journal-title":"Immunol. Rev."},{"key":"90434_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08830189809084486","volume":"17","author":"P Chomarat","year":"1998","unstructured":"Chomarat, P. & Banchereau, J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int. Rev. Immunol. 17, 1\u201352. https:\/\/doi.org\/10.3109\/08830189809084486 (1998).","journal-title":"Int. Rev. Immunol."},{"key":"90434_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12985-014-0230-z","volume":"11","author":"Y Guo","year":"2014","unstructured":"Guo, Y. et al. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis. Virol. J. 11, 230. https:\/\/doi.org\/10.1186\/s12985-014-0230-z (2014).","journal-title":"Virol. J."},{"key":"90434_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1465-9921-6-135","volume":"6","author":"MC Chan","year":"2005","unstructured":"Chan, M. C. et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 6, 135. https:\/\/doi.org\/10.1186\/1465-9921-6-135 (2005).","journal-title":"Respir. Res."},{"key":"90434_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcimb.2018.00009","volume":"8","author":"MH Kang","year":"2018","unstructured":"Kang, M. H., Jin, Y. H. & Kim, B. S. Effects of keratinocyte-derived cytokine (CXCL-1) on the development of Theiler\u2019s virus-induced demyelinating disease. Front. Cell Infect. Microbiol. 8, 9. https:\/\/doi.org\/10.3389\/fcimb.2018.00009 (2018).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"90434_CR53","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/nar\/gkt019","volume":"41","author":"RJ Lin","year":"2013","unstructured":"Lin, R. J. et al. MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation. Nucl. Acids Res. 41, 3314\u20133326. https:\/\/doi.org\/10.1093\/nar\/gkt019 (2013).","journal-title":"Nucl. Acids Res."},{"key":"90434_CR54","doi-asserted-by":"publisher","first-page":"12128","DOI":"10.1128\/JVI.75.24.12128-12140.2001","volume":"75","author":"A Bukreyev","year":"2001","unstructured":"Bukreyev, A., Belyakov, I. M., Berzofsky, J. A., Murphy, B. R. & Collins, P. L. Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells. J. Virol. 75, 12128\u201312140. https:\/\/doi.org\/10.1128\/JVI.75.24.12128-12140.2001 (2001).","journal-title":"J. Virol."},{"key":"90434_CR55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/cmi.2017.105","volume":"15","author":"W Zhao","year":"2018","unstructured":"Zhao, W., Zhao, G. & Wang, B. Revisiting GM-CSF as an adjuvant for therapeutic vaccines. Cell Mol. Immunol. 15, 187\u2013189. https:\/\/doi.org\/10.1038\/cmi.2017.105 (2018).","journal-title":"Cell Mol. Immunol."},{"key":"90434_CR56","doi-asserted-by":"publisher","unstructured":"M.S. Oberste, M. A. P. Coxsackieviruses. Encyclopedia of Virology, 3rd edn., 580\u2013587, https:\/\/doi.org\/10.1016\/B978-012374410-4.00372-1 (2008).","DOI":"10.1016\/B978-012374410-4.00372-1"},{"key":"90434_CR57","doi-asserted-by":"publisher","first-page":"7952","DOI":"10.1128\/jvi.74.17.7952-7962.2000","volume":"74","author":"NM Chapman","year":"2000","unstructured":"Chapman, N. M. et al. Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice. J. Virol. 74, 7952\u20137962. https:\/\/doi.org\/10.1128\/jvi.74.17.7952-7962.2000 (2000).","journal-title":"J. Virol."},{"key":"90434_CR58","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1089\/vim.2007.0077","volume":"21","author":"A Henke","year":"2008","unstructured":"Henke, A., Jarasch, N., Martin, U., Zell, R. & Wutzler, P. Characterization of the protective capability of a recombinant coxsackievirus B3 variant expressing interferon-gamma. Viral. Immunol. 21, 38\u201348. https:\/\/doi.org\/10.1089\/vim.2007.0077 (2008).","journal-title":"Viral. Immunol."},{"key":"90434_CR59","doi-asserted-by":"publisher","first-page":"8187","DOI":"10.1128\/jvi.75.17.8187-8194.2001","volume":"75","author":"A Henke","year":"2001","unstructured":"Henke, A., Zell, R., Ehrlich, G. & Stelzner, A. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis. J. Virol. 75, 8187\u20138194. https:\/\/doi.org\/10.1128\/jvi.75.17.8187-8194.2001 (2001).","journal-title":"J. Virol."},{"key":"90434_CR60","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.vaccine.2009.11.017","volume":"28","author":"DS Kim","year":"2010","unstructured":"Kim, D. S., Cho, Y. J., Kim, B. G., Lee, S. H. & Nam, J. H. Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector. Vaccine 28, 1234\u20131240. https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.017 (2010).","journal-title":"Vaccine"},{"key":"90434_CR61","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLOS Biol. 18, e3000410. https:\/\/doi.org\/10.1371\/journal.pbio.3000410 (2020).","journal-title":"PLOS Biol."},{"key":"90434_CR62","doi-asserted-by":"publisher","first-page":"7436","DOI":"10.1128\/JVI.00503-11","volume":"85","author":"J Pan","year":"2011","unstructured":"Pan, J. et al. Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor. J. Virol. 85, 7436\u20137443. https:\/\/doi.org\/10.1128\/JVI.00503-11 (2011).","journal-title":"J. Virol."},{"key":"90434_CR63","unstructured":"Dougherty, R. & Harris, R. Techniques in experimental virology. 169 (1964)."},{"key":"90434_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0002-9440(10)61685-9","volume":"159","author":"M Afanasyeva","year":"2001","unstructured":"Afanasyeva, M. et al. Experimental autoimmune myocarditis in A\/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am. J. Pathol. 159, 193\u2013203. https:\/\/doi.org\/10.1016\/S0002-9440(10)61685-9 (2001).","journal-title":"Am. J. Pathol."},{"key":"90434_CR65","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.cellimm.2011.08.013","volume":"271","author":"C Massilamany","year":"2011","unstructured":"Massilamany, C., Gangaplara, A., Steffen, D. & Reddy, J. Identification of novel mimicry epitopes for cardiac myosin heavy chain-alpha that induce autoimmune myocarditis in A\/J mice. Cell Immunol. 271, 438\u2013449. https:\/\/doi.org\/10.1016\/j.cellimm.2011.08.013 (2011).","journal-title":"Cell Immunol."},{"key":"90434_CR66","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.ajpath.2016.08.005","volume":"186","author":"RH Basavalingappa","year":"2016","unstructured":"Basavalingappa, R. H. et al. Identification of an epitope from adenine nucleotide translocator 1 that induces inflammation in heart in A\/J mice. Am. J. Pathol. 186, 3160\u20133175 (2016) (PMCID: PMC5225289).","journal-title":"Am. J. Pathol."},{"key":"90434_CR67","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4049\/jimmunol.1701090","volume":"200","author":"B Krishnan","year":"2018","unstructured":"Krishnan, B. et al. Epitope mapping of SERCA2a identifies an antigenic determinant that induces mainly atrial myocarditis in A\/J mice. J. Immunol. 200, 523\u2013537. https:\/\/doi.org\/10.4049\/jimmunol.1701090 (2018).","journal-title":"J. Immunol."},{"key":"90434_CR68","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1128\/MCB.25.4.1437-1445.2005","volume":"25","author":"S Storck","year":"2005","unstructured":"Storck, S. et al. Normal immune system development in mice lacking the Deltex-1 RING finger domain. Mol. Cell. Biol. 25, 1437\u20131445 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"90434_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2009.11.006","volume":"219","author":"C Massilamany","year":"2010","unstructured":"Massilamany, C., Steffen, D. & Reddy, J. An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139\u2013151-reactive T cells induces autoimmune encephalomyelitis in SJL mice. J. Neuroimmunol. 219, 17\u201324. https:\/\/doi.org\/10.1016\/j.jneuroim.2009.11.006 (2010).","journal-title":"J. Neuroimmunol."},{"key":"90434_CR70","doi-asserted-by":"publisher","first-page":"870","DOI":"10.4049\/jimmunol.170.2.870","volume":"170","author":"J Reddy","year":"2003","unstructured":"Reddy, J. et al. Detection of autoreactive myelin proteolipid protein 139\u2013151-specific T cells by using MHC II (IAs) tetramers. J. Immunol. 170, 870\u2013877. https:\/\/doi.org\/10.4049\/jimmunol.170.2.870 (2003).","journal-title":"J. Immunol."},{"key":"90434_CR71","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jim.2011.07.004","volume":"372","author":"C Massilamany","year":"2011","unstructured":"Massilamany, C., Gangaplara, A., Chapman, N., Rose, N. & Reddy, J. Detection of cardiac myosin heavy chain-alpha-specific CD4 cells by using MHC class II\/IA(k) tetramers in A\/J mice. J. Immunol. Methods 372, 107\u2013118. https:\/\/doi.org\/10.1016\/j.jim.2011.07.004 (2011).","journal-title":"J. Immunol. Methods"},{"key":"90434_CR72","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/iid3.177","volume":"4","author":"B Krishnan","year":"2017","unstructured":"Krishnan, B. et al. Branched chain \u03b1-ketoacid dehydrogenase kinase 111\u2013130, a T cell epitope that induces both autoimmune myocarditis and hepatitis in A\/J mice. Immun. Inflamm. Disease 4, 421\u2013434 (2017).","journal-title":"Immun. Inflamm. Disease"},{"key":"90434_CR73","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.cellimm.2011.08.013","volume":"271","author":"C Massilamany","year":"2011","unstructured":"Massilamany, C., Gangaplara, A., Steffen, D. & Reddy, J. Identification of novel mimicry epitopes for cardiac myosin heavy chain-\u03b1 that induce autoimmune myocarditis in A\/J mice. Cell. Immunol. 271, 438\u2013449 (2011).","journal-title":"Cell. Immunol."},{"key":"90434_CR74","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/156177a0","volume":"156","author":"GA Barnard","year":"1945","unstructured":"Barnard, G. A. A new test for 2 \u00d7 2 tables. Nature 156, 177\u2013177. https:\/\/doi.org\/10.1038\/156177a0 (1945).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90434-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90434-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90434-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T21:36:05Z","timestamp":1699133765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-90434-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["90434"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-90434-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"assertion":[{"value":"26 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Board of Regents of the University of Nebraska is an applicant of a pending provisional patent application (# 63\/179,980). N.L., A.G., C.M., M.T.R., A.K.P. and J.R. are listed as inventors on the pending patent application and the inventors have contributed to the creation and use of vaccine virus described in this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12432"}}